Chiesi launches ‘The Impulse’ to drive innovation and collaboration in healthcare

the impulse

Chiesi Group, a research-oriented international biopharmaceutical group, is proud to announce the official launch of The Impulse, an innovation platform designed to accelerate bold ideas and meaningful partnerships in healthcare.

The Impulse aims to tackle some of the biggest challenges facing patients, the planet, and people today by addressing not only symptoms but also the root causes of these challenges, such as climate change and access to care.

Chiesi continuously invests in research and development to create new healthcare solutions for patients globally.

Empowering innovation through collaboration

The Impulse was launched at Frontiers Health in Berlin. The platform will provide resources, mentorship, and a global network for innovators, researchers, and startups to bring forward-thinking healthcare solutions to life.

The Impulse has already begun to attract interest from key players in the life sciences, digital health, and environmental sustainability sectors, including the Karolinska Institutet, NOME and EIT-HEALTH, with more partnerships in the pipeline.

The platform will also serve as a dynamic hub for collaboration, connecting innovators to a global network of resources to drive new projects and ideas forward.

A commitment to patients and the planet

As the healthcare industry faces growing pressure to rethink traditional care models, with climate change and sustainability central to global health discussions, Chiesi is offering more environmentally friendly solutions.

The Impulse creates a collaborative space for researchers, start-ups and innovators to work together to drive solutions that not only improve patient outcomes but also contribute to a healthier planet for future generations.

Sustainability is deeply rooted in Chiesi’s strategy and vision. Since 2018, the Company has adopted the Benefit Corporation legal status in Italy, the US, and France, and it constantly monitors its ESG performances through the B Corp certification measurement framework.

 “We stand at a pivotal moment for the pharmaceutical industry. This is the time to further rethink traditional models and embrace bolder, patient-centric innovation. That’s why Chiesi has created The Impulse, aiming to empower those who are driven by a passion to improve the lives of others through innovation,” said Fabrizio Conicella, Vice-President Center of Open Innovation & Competence.

“We know that some of the most groundbreaking ideas come from collaboration. By providing the resources, network, and support, we aim to accelerate ideas that will have a tangible impact on patients and the world around us, perfectly in line with our Company vision.”

Forward-thinking healthcare solutions

As Chiesi continues to pioneer solutions at the intersection of healthcare and sustainability, The Impulse implementing Open Innovation mechanism and tools, marks a significant step forward in creating a future where technology, patient care, and environmental responsibility converge. This platform not only aims to improve patient outcomes but also addresses wider societal challenges, underlining Chiesi’s ongoing commitment to innovation and sustainability.

The Impulse, being technology agnostic, is designed to meet the growing for pharma and healthcare solutions that meet the real needs of patients.

Chiesi is also committed to empower the next generation of digital health solutions from wearable technology to AI-driven diagnostics and telemedicine systems that connect patients with providers globally. The Impulse is driving forward-thinking healthcare solutions, from digital health to sustainable patient care, with the potential to transform the industry.

For more information on The Impulse and how to get involved, visit https://www.chiesi.com/en/about-us/the-impulse/

Contributor Details

Carla Arrieta Martinez

Chiesi Group
Phone: +39 0521 1689404
Website: Visit Website
Subscribe to our newsletter

LEAVE A REPLY

Please enter your comment!
Please enter your name here